Omnipaque
Active substance: iohexol
INJECTION, SOLUTION · IOHEXOL 300 mg/mL
United StatesActive
Marketing holder: GE Healthcare Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- IOHEXOL · 300 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-34f2-775e-964a-bc19543ae355,01a1208d-ac59-7ea9-85e7-b1e0639ecefb,01a1208d-cbf1-74df-8d72-af3816fcae85,01a1208e-e8c8-7453-9ee4-04b022cc200b,01a1208f-26f4-793c-867c-c0dd73e88532;count=15 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0407-1413
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRA-ARTICULAR, INTRATHECAL, INTRAVASCULAR, INTRAVENOUS, ORAL, RECTAL
Sources
- product · openFDA NDC · 0407-1413 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0407-1413 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0407-1413 · Verified 2026-10-09 · open in source